Globus Medical Inc
GMED- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001237831
In the last 90 days, Globus Medical Inc insiders filed 0 open-market purchases and 2 sales; 601 institutions reported holding it in 13F filings for Q2 2026, worth $9.43B in total; no superinvestor holds it.
Holders of 5% or more of GMED
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Globus Medical Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 9.10%10.5M shares | +1.30 ppfrom 7.80% | Feb 5, 20252 filings | Apr 24, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 6.10%7.03M shares | +0.30 ppfrom 5.80% | Feb 11, 20217 filings | May 14, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 5.22%5.89M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
29 Schedule 13D and 13G filings on Globus Medical Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 202610:33 AM ET | Vanguard Capital Management LLC | 13G | 5.22%5.89M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20266:39 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| May 14, 202512:28 PM ET | Janus Henderson Group PLC | 13G/A | 6.10%7.03M shares | +0.30 ppfrom 5.80% | Mar 31, 2025 | SEC |
| Apr 24, 20259:27 AM ET | BlackRock, Inc. | 13G/A | 9.10%10.5M shares | +1.30 ppfrom 7.80% | Mar 31, 2025 | SEC |
| Feb 14, 202512:34 PM ET | Janus Henderson Group PLC | 13G/A | 5.80%6.61M shares | – | Dec 31, 2024 | SEC |
| Feb 5, 20251:23 PM ET | BlackRock, Inc. | 13G/A | 7.80%10.6M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Paul David C | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Kayne Anderson Rudnick Investment Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 24, 20245:23 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Sep 11, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Sep 7, 20239:38 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Kayne Anderson Rudnick Investment Management LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Paul David C | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 24, 20231:56 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Paul David C | 13G/AOld format | – | – | – | SEC |
| Feb 7, 20224:40 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Paul David C | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2021 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
| Jan 29, 20219:56 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
7 notices from officers, directors and other affiliates planning to sell Globus Medical Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| May 10, 20244:15 PM ET | Lemaitre DanDirector | 52.5K | $3.39M | May 10, 2024 | Raymond James & Associates, Inc. | SEC |
| May 10, 202412:11 PM ET | Lemaitre DanDirector | 10.8K | $693.8K | May 10, 2024 | Raymond James & Associates | SEC |
| May 8, 20244:11 PM ET | Davidar David DDirector | 3.50K | $227.3K | May 8, 2024 | Raymond James & Associates | SEC |
| May 8, 20243:59 PM ET | Davidar David DDirector | 20.0K | $1.30M | May 8, 202410b5-1 | Raymond James & Associates | SEC |
| Mar 15, 202411:02 AM ET | Norwalk Leslie VDirector | 10.6K | $550.0K | Mar 15, 202410b5-1 | Raymond James & Associates, Inc. | SEC |
| Mar 1, 20246:50 PM ET | Huller KellyOfficer | 7.50K | $405.3K | Mar 1, 2024 | Raymond James & Associates, Inc. | SEC |
| May 16, 20234:18 PM ET | Lemaitre DanDirector | 43.5K | $2.47M | May 15, 2023 | Raymond James & Associates Inc | SEC |